Journal of Clinical Epidemiology
Volume 64, Issue 4 , Pages 424-430 , April 2011

Routine health insurance data for scientific research: potential and limitations of the Agis Health Database

  • Hugo M. Smeets

      Affiliations

    • Corresponding Author InformationCorresponding author. Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Universiteitsweg 100, PO Box 85500, 3508 GA Utrecht, The Netherlands. Tel.: +31-887553012; fax: +31-887555480.
    • ,
  • Niek J. de Wit
    • ,
  • Arno W. Hoes

,Accepted 26 April 2010.

References 

  1. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323–337Review
  2. Vandenbroucke JP. When are observational studies as credible as randomised trials?. Lancet. 2004;363:1728–1731
  3. Cohen D, Longo MF, Williams J, Cheung WY, Hutchings H, Russell IT. Estimating the marginal value of “better” research output: “designed” versus “routine” data in randomised controlled trials. Health Econ. 2003;12:959–974
  4. Lanza AJ, McConnell WJ, Fehnel JW. Effects of the inhalation of asbestos dust on the lungs of asbestos workers: a preliminary study. Public Health Rep. 1935;50:1–12
  5. Greenland S, Finkle WD. A retrospective cohort study of implantable medical devices and selected chronic disease in Medicare claims data. Ann Epidemiol. 2000;10:205–213
  6. Rodrigues EM, Staffa JA, Graham DJ. The role of databases in drug postmarketing surveillance. Parmacoepidemiol Drug Saf. 2001;10:407–410
  7. Smeets HM, Kuyvenhoven MM, Akkerman AE, Welschen I, Schouten GP, van Essen GA, et al. Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study. Fam Pract. 2009;26:183–187
  8. Ihle P, Köster I, Herholz H, Rambow-Bertram P, Schardt T, Schubert I. Sample survey of persons insured in statutory health insurance institutions in Hessen: concept and realisation of person-related data base. Das Gesundheitswesen. 2005;67:638–645
  9. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455–461
  10. Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, et al. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on therapeutics. Pharmacoepidemiol Drug Saf. 2001;10:373–377
  11. Peter R, Geyer S. School and vocational education, occupational status, and myocardial infarction: a study based on statutory health insurance data. Das Gesundheitswesen. 1999;61:20–26
  12. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42:937–945
  13. Wang PS, Walker A, Tsuang M, Orav EJ, Levin R, Avorn J. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. J Clin Epidemiol. 2000;53:571–578
  14. Fung V, Huang J, Newhouse JP, Hsu J. Hypertension treatment in a medicare population: adherence and systolic pressure control. Clin Ther. 2007;29:972–984
  15. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol. 1996;25:435–442Review
  16. Maclure M, Schneeweiss S. Causation of bias: the episcope. Epidemiology. 2001;12:114–122
  17. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57:131–141
  18. Hennessy S, Bilker WB, Weber A, Strom BL. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf. 2003;12:103–111
  19. Hutchings HA, Cheung WY, Williams JG, Cohen D, Longo MF, Russell I. Can electronic routine data act as a surrogate for patient-assessed outcome measures?. Int J Technol Assess Health Care. 2005;21:138–143
  20. Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol. 2005;58:98–102
  21. Williams JG, Cheung WY, Cohen DR, Hutchings HA, Longo MF, Russell IT. Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment. Health Technol Assess. 2003;7:iii;1–117
  22. Laan W, Selten JP, Grobbee DE, Smeets H, Kahn RS, Burger H. Non-steroidal anti-inflammatory drugs and the risk of psychosis. Eur Neuropsychopharmacol. 2007;17:309–311
  23. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006;44:471–477
  24. Grobbee DE, Hoes WA. Clinical epidemiology: principles, methods and applications for clinical research. Sudbury, MA: Jones and Bartlett; 2008;
  25. Van der ADL, Peeters PHM, Grobbee DE, Marx JJM, Van der Schouw Y. Dietary haem iron and coronary heart disease in women. Eur Hart J. 2005;26:257–262
  26. Boelman L, Smeets HM, Knol MJ, Braam AW, Grobbee DE, Geerlings MI, et al. Mental disorders in patients with various chronic somatic diseases. Int Clin Psychopharm [in press].
  27. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854–864
  28. Smeets HM, De Wit NJ, Zuithoff NPA, Van Dijk PCM, Van der Lee APM, Hoes AW. A health insurance company initiated multi-facetted intervention for optimising acid-suppressing drug prescriptions in primary care; a randomised controlled trial. Arch Intern Med. 2010;170:1264–1268
  29. Roovers MM, Glasziou P, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, et al. Predictors of a prolonged course in children with acute otitis media: an individual patient data meta-analysis. Pediatrics. 2007;119:579–585
  30. Helsper CW, Smeets HM, Numans ME, Knol MJ, Hoes AW, De Wit NJ. Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs. Pharmacoepidemiol Drug Saf. 2009;18:800–806

PII: S0895-4356(10)00211-8

doi: 10.1016/j.jclinepi.2010.04.023

Journal of Clinical Epidemiology
Volume 64, Issue 4 , Pages 424-430 , April 2011

Article Tools

* Image Usage & Resolution